Esperion Therapeutics, Inc. — All Filings
875 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
NT 10-Q
PRE 14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001245 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-019413 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019411 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019409 | Mar 18, 2026 | Mar 17, 2026 |
| 144 | — | 0001959173-26-002427 | Mar 17, 2026 | — |
| 144 | — | 0001959173-26-002426 | Mar 17, 2026 | — |
| 144 | — | 0001959173-26-002423 | Mar 17, 2026 | — |
| 4 | FORM 4 | 0001628280-26-018194 | Mar 16, 2026 | Mar 13, 2026 |
| 4 | FORM 4 | 0001628280-26-018192 | Mar 16, 2026 | Mar 13, 2026 |
| 4 | FORM 4 | 0001628280-26-018186 | Mar 16, 2026 | Mar 13, 2026 |
| 10-K | 10-K | 0001628280-26-016522 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-016230 | Mar 10, 2026 | — |
| 8-K | 8-K | 0001628280-26-013552 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-002925 | Jan 21, 2026 | Jan 20, 2026 |
| 144 | — | 0001959173-26-000363 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001628280-26-001764 | Jan 12, 2026 | Jan 11, 2026 |
| 4 | FORM 4 | 0001628280-25-057944 | Dec 18, 2025 | Dec 17, 2025 |
| 4 | FORM 4 | 0001628280-25-057942 | Dec 18, 2025 | Dec 17, 2025 |
| 4 | FORM 4 | 0001628280-25-057941 | Dec 18, 2025 | Dec 17, 2025 |
| 144 | — | 0001959173-25-007814 | Dec 17, 2025 | — |
| 144 | — | 0001959173-25-007813 | Dec 17, 2025 | — |
| 144 | — | 0001959173-25-007812 | Dec 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-055842 | Dec 8, 2025 | Dec 4, 2025 |
| 3 | FORM 3 | 0001628280-25-052595 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001011438-25-000555 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000814133-25-000106 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-050165 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-049866 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001628280-25-048557 | Nov 4, 2025 | — |
| 4 | FORM 4 | 0001628280-25-045520 | Oct 20, 2025 | Oct 17, 2025 |
| 144 | — | 0001959173-25-006479 | Oct 17, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-097992 | Oct 8, 2025 | Oct 7, 2025 |
| 424B5 | 424B5 | 0001104659-25-097988 | Oct 8, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-097524 | Oct 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-097506 | Oct 7, 2025 | — |
| 4 | FORM 4 | 0001859509-25-000004 | Sep 18, 2025 | Sep 17, 2025 |
| 4 | FORM 4 | 0001766524-25-000004 | Sep 18, 2025 | Sep 17, 2025 |
| 4 | FORM 4 | 0001953943-25-000004 | Sep 18, 2025 | Sep 17, 2025 |
| 144 | — | 0001959173-25-006080 | Sep 17, 2025 | — |
| 144 | — | 0001959173-25-006079 | Sep 17, 2025 | — |
| 144 | — | 0001959173-25-006078 | Sep 17, 2025 | — |
| SCHEDULE 13G | — | 0001315863-25-000610 | Aug 13, 2025 | — |
| S-8 | S-8 | 0001628280-25-040152 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-040139 | Aug 13, 2025 | Jun 30, 2025 |
| NT 10-Q | NT 10-Q | 0001628280-25-039562 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K/A | 8-K/A | 0001628280-25-039392 | Aug 11, 2025 | Aug 5, 2025 |
| 8-K | 8-K | 0001628280-25-037601 | Aug 5, 2025 | — |
| 4 | FORM 4 | 0001628280-25-035336 | Jul 18, 2025 | Jul 17, 2025 |
| 4 | FORM 4 | 0001628280-25-035334 | Jul 18, 2025 | Jul 17, 2025 |
| 144 | — | 0001959173-25-004633 | Jul 17, 2025 | — |